1189 related articles for article (PubMed ID: 8886430)
21. Failure of L-nitroarginine to inhibit the activity of aortic inducible nitric oxide synthase.
Darblade B; Batkai S; Caussé E; Gourdy P; Fouque MJ; Rami J; Arnal JF
J Vasc Res; 2001; 38(3):266-75. PubMed ID: 11399899
[TBL] [Abstract][Full Text] [Related]
22. Effect of Tityus serrulatus scorpion venom on the rabbit isolated corpus cavernosum and the involvement of NANC nitrergic nerve fibres.
Teixeira CE; Bento AC; Lopes-Martins RA; Teixeira SA; von Eickestedt V; Muscará MN; Arantes EC; Giglio JR; Antunes E; de Nucci G
Br J Pharmacol; 1998 Feb; 123(3):435-42. PubMed ID: 9504384
[TBL] [Abstract][Full Text] [Related]
23. A comparison of the effects of L-NAME, 7-NI and L-NIL on carrageenan-induced hindpaw oedema and NOS activity.
Handy RL; Moore PK
Br J Pharmacol; 1998 Mar; 123(6):1119-26. PubMed ID: 9559895
[TBL] [Abstract][Full Text] [Related]
24. Nitric oxide modulates the cardiovascular effects elicited by acetylcholine in the NTS of awake rats.
da Silva LG; Dias AC; Furlan E; Colombari E
Am J Physiol Regul Integr Comp Physiol; 2008 Dec; 295(6):R1774-81. PubMed ID: 18815211
[TBL] [Abstract][Full Text] [Related]
25. Fire ant venom alkaloid, isosolenopsin A, a potent and selective inhibitor of neuronal nitric oxide synthase.
Yi GB; McClendon D; Desaiah D; Goddard J; Lister A; Moffitt J; Meer RK; deShazo R; Lee KS; Rockhold RW
Int J Toxicol; 2003; 22(2):81-6. PubMed ID: 12745988
[TBL] [Abstract][Full Text] [Related]
26. L-NAME inhibits Mg(2+)-induced rat aortic relaxation in the absence of endothelium.
Das R; Kravtsov GM; Ballard HJ; Kwan CY
Br J Pharmacol; 1999 Sep; 128(2):493-9. PubMed ID: 10510463
[TBL] [Abstract][Full Text] [Related]
27. Role of neuronal nitric-oxide synthase in estrogen-induced relaxation in rat resistance arteries.
Lekontseva O; Chakrabarti S; Jiang Y; Cheung CC; Davidge ST
J Pharmacol Exp Ther; 2011 Nov; 339(2):367-75. PubMed ID: 21807885
[TBL] [Abstract][Full Text] [Related]
28. Potentiation of the vasorelaxant activity of nitric oxide by hydroxyguanidine: implications for the nature of endothelium-derived relaxing factor.
Zembowicz A; Swierkosz TA; Southan GJ; Hecker M; Vane JR
Br J Pharmacol; 1992 Dec; 107(4):1001-7. PubMed ID: 1281716
[TBL] [Abstract][Full Text] [Related]
29. L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro.
Moore PK; al-Swayeh OA; Chong NW; Evans RA; Gibson A
Br J Pharmacol; 1990 Feb; 99(2):408-12. PubMed ID: 2328404
[TBL] [Abstract][Full Text] [Related]
30. In vivo and in vitro evidence of altered nitric oxide metabolism in the spontaneously diabetic, insulin-dependent BB/Edinburgh rat.
Lindsay RM; Peet RS; Wilkie GS; Rossiter SP; Smith W; Baird JD; Williams BC
Br J Pharmacol; 1997 Jan; 120(1):1-6. PubMed ID: 9117082
[TBL] [Abstract][Full Text] [Related]
31. Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine- and endomorphin-1-induced analgesia in acute and neuropathic pain in rats.
Makuch W; Mika J; Rojewska E; Zychowska M; Przewlocka B
Neuropharmacology; 2013 Dec; 75():445-57. PubMed ID: 24035921
[TBL] [Abstract][Full Text] [Related]
32. L-NG-nitro arginine p-nitroanilide (L-NAPNA) is anti-nociceptive in the mouse.
Babbedge RC; Wallace P; Gaffen ZA; Hart SL; Moore PK
Neuroreport; 1993 Mar; 4(3):307-10. PubMed ID: 7682856
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine.
Pfeiffer S; Leopold E; Schmidt K; Brunner F; Mayer B
Br J Pharmacol; 1996 Jul; 118(6):1433-40. PubMed ID: 8832069
[TBL] [Abstract][Full Text] [Related]
34. Alterations of the nitric oxide pathway in cerebral arteries from spontaneously hypertensive rats.
Briones AM; Alonso MJ; Hernanz R; Miguel M; Salaices M
J Cardiovasc Pharmacol; 2002 Mar; 39(3):378-88. PubMed ID: 11862117
[TBL] [Abstract][Full Text] [Related]
35. Role of nitric oxide synthase isoforms for ophthalmic artery reactivity in mice.
Laspas P; Goloborodko E; Sniatecki JJ; Kordasz ML; Manicam C; Wojnowski L; Li H; Patzak A; Pfeiffer N; Gericke A
Exp Eye Res; 2014 Oct; 127():1-8. PubMed ID: 25017185
[TBL] [Abstract][Full Text] [Related]
36. Differential effects of L-arginine on the inhibition by NG-nitro-L-arginine methyl ester of basal and agonist-stimulated EDRF activity.
Randall MD; Griffith TM
Br J Pharmacol; 1991 Nov; 104(3):743-9. PubMed ID: 1797335
[TBL] [Abstract][Full Text] [Related]
37. Selective iNOS inhibition attenuates acetylcholine- and bradykinin-induced vasoconstriction in lipopolysaccharide-exposed rat lungs.
Fischer LG; Horstman DJ; Hahnenkamp K; Kechner NE; Rich GF
Anesthesiology; 1999 Dec; 91(6):1724-32. PubMed ID: 10598616
[TBL] [Abstract][Full Text] [Related]
38. Endothelial nitric oxide modulates perivascular sensory neurotransmission in the rat isolated mesenteric arterial bed.
Ralevic V
Br J Pharmacol; 2002 Sep; 137(1):19-28. PubMed ID: 12183327
[TBL] [Abstract][Full Text] [Related]
39. Vascular reactivity in mesenteric resistance arteries following chronic nitric oxide synthase inhibition in Wistar rats.
Dowell FJ; Henrion D; Duriez M; Michel JB
Br J Pharmacol; 1996 Jan; 117(2):341-6. PubMed ID: 8789388
[TBL] [Abstract][Full Text] [Related]
40. Co-expression and modulation of neuronal and endothelial nitric oxide synthase in human endothelial cells.
Bachetti T; Comini L; Curello S; Bastianon D; Palmieri M; Bresciani G; Callea F; Ferrari R
J Mol Cell Cardiol; 2004 Nov; 37(5):939-45. PubMed ID: 15522271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
